ALVOTECH |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.35 USD | +0.45% |
|
-7.58% | +42.32% |
| 04-30 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
| 04-30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 48.16B | - | |||||
| 41.73B | ||||||
| 41.03B | ||||||
| 28.77B | ||||||
| 25.59B |
- Stock Market
- Equities
- ALVO Stock
- ALVO Stock
- Charts Alvotech
- Sector Chart
